ESA Laboratories says that the reporting limit for the most widely used pharmaceutical surrogate, lactose, has been lowered to 0.5ng per sample
Using the ESA Coulochem III detector, a proprietary gold target electrode, and other advances in chromatography, the reporting limit for lactose in air has been lowered to 0.5ng/filter-down from 2ng in 2002 and 25ng per filter in 1996.
According to ESA Laboratories's laboratory director, Pauline Lambert, its reporting limits for surrogate monitoring are the lowest available in the industry.
A reporting limit of 0.5ng for lactose is a real breakthrough.
One of the wonders of modern medicine has been the development of powerful new pharmaceutical compounds.
With these new potent drugs, the risks of exposure in the development and manufacturing processes are increasing; the need for monitoring containment is greater than ever.
Using ESA Bioscience's proprietary electrochemical technology, that includes the best in both amperometric and coulometric detectors, reporting limits for lactose (0.5ng / filter), mannitol (1ng / filter), naproxen (0.25ng / filter), and acetaminophen (0.5ng / filter) are the lowest available.
ESA Laboratories, a wholly owned subsidiary of ESA Biosciences, delivers analytical results utilising ESA's various detector technologies.
